Portfolio company
Ataraxis
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops artificial intelligence diagnostic tools for breast cancer to help clinicians predict treatment response and recurrence risk from patient data.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ataraxis AI
This company develops artificial intelligence models that predict cancer outcomes and treatment responses for healthcare providers and oncologists.
Artera
This company develops artificial intelligence tests that predict cancer outcomes and treatment benefits for clinicians and their patients.
Elaitra
The company develops an artificial intelligence platform to assist radiologists in the early detection and diagnosis of breast cancer.
StratifAI
This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Digistain
This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.
Health Triage
This company develops artificial intelligence software for early cancer detection and clinical diagnosis to assist healthcare facilities and medical professionals.
Qlarity Imaging
This company develops artificial intelligence software to assist radiologists in the diagnosis and characterisation of breast abnormalities from medical imaging data.
